Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., An unknown mechanistic insight into how analgesics promote weight loss: Paracetamol (4-Hydroxyacetanilide) inhibits hepatic steatosis and promotes weight loss via down regulation of Nocturnin, 23/February/2015, 15.49, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Significance: This study suggests that, Paracetamol (4-Hydroxyacetanilide), by increasing the expression of its target gene, it may decrease the expression of Nocturnin, and thereby promote weight loss. Thus, pharmacological formulations encompassing “Paracetamol (4-Hydroxyacetanilide) or its analogues (free of side effects)“ in non-lethal doses may be used to promote weight loss.
Undisclosed information: How Paracetamol (4-Hydroxyacetanilide) suppresses the expression of Nocturnin
Amount: $500*
* Research cooperation